This drug has been approved for the treatment of multiple chronic inflammatory disorders.
This drug has been approved for the treatment of multiple chronic inflammatory disorders.
Simlandi injection was approved for arthritic conditions, while Namzaric receives its first generic approval.
Spending and utilization are returning to pre-pandemic levels, with biologics growing in prominence.
This autoimmune drug was approved for various arthritic and autoimmune diseases.
Migraine, arthritis, and insomnia drug approvals, and a gabapentinoids safety warning.
A biosimilar to Humira is approved, the FDA Fast Tracks a PTSD drug, and more.
